5,8,11,14-eicosatetraenamide, N-(4-hydroxyphenyl)-, (5Z,8Z,11Z,14Z)-,
5,8,11,14-eicosatetraenamide, N-(4-hydroxyphenyl)-, (all-Z)-,
AM 404,
AM-404,
AM404,
N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide,
N-(4-hydroxyphenyl)arachidonylamide,
AM 404,
AM-404,
183718-77-6,
am404,
UNII-XVJ94H0U21,
198022-70-7,
CHEMBL39878,
XVJ94H0U21,
CPD000449274,
(5Z,8Z,11Z,14Z)-N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide,
N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide,
SMR000449274,
SR-01000597390,
N-(4-Hydroxyphenyl)-arachidonylamide,
N-(4-Hydroxyphenyl)arachidonylamide,
N-(4-Hydroxyphenyl)arachidonoyl amide,
NCGC00025010-01,
Tocris-1116,
AC1O7GXA,
5,8,11,14-Eicosatetraenamide, N-(4-hydroxyphenyl)-, (all-Z)-,
N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide,
5,8,11,14-Eicosatetraenamide, N-(4-hydroxyphenyl)-, (5Z,8Z,11Z,14Z)-,
MLS000758246,
MLS001424005,
SCHEMBL157919,
cid_6604822,
AOB5958,
DTXSID60424985,
IJBZOOZRAXHERC-DOFZRALJSA-N,
HMS2051K03,
HMS3649D03,
HMS3676I19,
ZINC3871503,
BDBM50054471,
BN0065,
MFCD03095721,
AKOS024456392,
CCG-100756,
NC00006,
ACM198022707,
SAM001246965,
B6604,
J-011774,
SR-01000597390-1,
SR-01000597390-6,
N-(4-Hhydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetrenamide,
N-(4-Hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide,
Icosa-5,8,11,14-tetraenoic acid (4-hydroxy-phenyl)-amide,
(all-Z)-N-(4-Hydroxyphenyl)-5,8,11,14-eicosatetraenamide,
N-(4-Hydroxyphenyl)-arachidonylamide, >=98%, ethanol solution,
(5Z,8Z)-Icosa-5,8,11,14-tetraenoic acid (4-hydroxy-phenyl)-amide,
(5Z,8Z,11Z,14Z)-N-(4-Hydroxyphenyl)-5,8,11,14-eicosatetraenamide,
(8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid (4-hydroxy-phenyl)-amide,
N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide,
(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid (4-hydroxy-phenyl)-amide,
AM 404 (in Tocrisolvetrade mark 100)|N-(4-Hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide,
CID6604822,
C107594,